Arkolith/Insider Trading/AMAM/Form 4

Darwin Global Master Fund, Ltd.

10% OwnerAmbrx Biopharma Inc. (AMAM) · full profile →Form 4 · filed Jun 28, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 27, 2023Buy(P)5.4M$13.93$75.0M16.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-23-003751) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML